Page last updated: 2024-08-17

physostigmine and Movement Disorders

physostigmine has been researched along with Movement Disorders in 23 studies

Research

Studies (23)

Timeframe	Studies, this research(%)	All Research%
pre-1990	22 (95.65)	18.7374
1990's	1 (4.35)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
ENDROECZI, E; KORANYI, L; LISSAK, K	1
Edge, PC; Grell, GA; Melville, GN; Wray, SR	1
Grimm, RJ	2
Barchas, JD; Berger, PA; Davis, KL; Hollister, LE	1
Casey, DE	1
Berger, PA; Davis, KL	1
Battista, AF; Goldstein, M; Miyamoto, T	1
Pasik, P; Pasik, T	1
Lai, C; Tolosa, ES	1
Anlezark, GM; Marsden, CD; Meldrum, BS	1
Extein, I	1
Boyce, S; Iversen, SD; Rupniak, NM; Steventon, MJ; Tye, SJ	1
Jenner, P; Marsden, CD; Rupniak, NM	1
Abel, LA; Dell'Osso, LF; Leigh, RJ; Thurston, SE	1
Carman, JS	1
Bachmann, T; Jurna, I; Theres, C	1
Constantinidis, J	1
Fann, WE; Gerber, CJ; Lake, CR; McKenzie, GM	1
Klawans, HL; Rubovits, R	1
Gerlach, J; Randrup, A; Reisby, N	1
Klawans, HL; Patel, BC; Rubovits, R; Weiner, WJ	1
Van Woert, MH; Weintraub, MI	1

Reviews

3 review(s) available for physostigmine and Movement Disorders

Article	Year
Current concepts of abnormal motor disorder: an experimental model of attentional deficit disorder. The West Indian medical journal, 1981, Volume: 30, Issue:3 Topics: Amphetamine; Animals; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Avoidance Learning; Brain; Cholinesterase Inhibitors; Dyskinesia, Drug-Induced; gamma-Aminobutyric Acid; Humans; Huntington Disease; Hyperkinesis; Models, Neurological; Movement Disorders; Nervous System Diseases; Neurotransmitter Agents; Parkinson Disease; Physostigmine; Rats	1981
Deanol in the management of involuntary movement disorders: a review. Diseases of the nervous system, 1977, Volume: 38, Issue:12 Pt 2 Topics: Acetylcholine; Deanol; Dopamine; Dyskinesia, Drug-Induced; Ethanolamines; Female; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Models, Neurological; Movement Disorders; Parkinson Disease; Physostigmine; Research Design; Time Factors	1977
Acute dystonia induced by neuroleptic drugs. Psychopharmacology, 1986, Volume: 88, Issue:4 Topics: Acute Disease; alpha-Methyltyrosine; Animals; Antipsychotic Agents; Brain; Chlorpromazine; Disease Models, Animal; Drug Synergism; Dystonia; Fluphenazine; Haloperidol; Histamine H1 Antagonists; Levodopa; Mastication; Methyltyrosines; Movement Disorders; Parasympatholytics; Physostigmine; Primates; Rats	1986

Trials

3 trial(s) available for physostigmine and Movement Disorders

Article	Year
Pharmacological investigations of the cholinergic imbalance hypotheses of movement disorders and psychosis. Biological psychiatry, 1978, Volume: 13, Issue:1 Topics: Acetylcholine; Adult; Aged; Bipolar Disorder; Brain; Choline; Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Huntington Disease; Male; Middle Aged; Movement Disorders; Physostigmine; Psychotic Disorders; Receptors, Cholinergic; Schizophrenia	1978
Meige disease: striatal dopaminergic preponderance. Neurology, 1979, Volume: 29, Issue:8 Topics: Aged; Apomorphine; Basal Ganglia; Blepharospasm; Clinical Trials as Topic; Diagnosis, Differential; Eyelid Diseases; Facial Muscles; Female; Haloperidol; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Physostigmine; Placebos	1979
Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia. Psychopharmacologia, 1974, Jan-09, Volume: 34, Issue:1 Topics: Adult; Age Factors; Aged; Biperiden; Clinical Trials as Topic; Dihydroxyphenylalanine; Dopamine; Female; Humans; Male; Methyltyrosines; Middle Aged; Movement Disorders; Parasympathetic Nervous System; Physostigmine; Scopolamine; Time Factors	1974

Other Studies

17 other study(ies) available for physostigmine and Movement Disorders

Article	Year
HYPERMOTILITY EVOKED BY LESIONS OF THE SEPTUM AND ANTERIOR HYPOTHALAMUS. Acta physiologica Academiae Scientiarum Hungaricae, 1963, Volume: 23 Topics: Aminopyrine; Amygdala; Atropine; Body Temperature; Caudate Nucleus; Cerebral Ventricles; Chlorpromazine; Electrocoagulation; Ephedrine; Hexobarbital; Hippocampus; Hypothalamus; Hypothalamus, Anterior; Imipramine; Iproniazid; Metabolism; Morphine; Movement Disorders; Physostigmine; Rats; Research; Reserpine; Scopolamine	1963
Disorderly walks. Neurologic clinics, 1984, Volume: 2, Issue:3 Topics: Ataxia; Cerebellar Ataxia; Gait; Humans; Male; Middle Aged; Movement Disorders; Physostigmine; Terminology as Topic	1984
Program disorders of movement. Advances in neurology, 1983, Volume: 39 Topics: Brain Diseases; Central Nervous System Diseases; Cerebellar Ataxia; Diagnosis, Differential; Electromyography; H-Reflex; Humans; Motor Neurons; Movement Disorders; Multiple Sclerosis; Muscle Spasticity; Parkinson Disease; Physostigmine; Reflex, Stretch	1983
Cholinergic imbalance hypotheses of psychoses and movement disorders: strategies for evaluation. Psychopharmacology communications, 1975, Volume: 1, Issue:5 Topics: Biogenic Amines; Bipolar Disorder; Humans; Huntington Disease; Movement Disorders; Parasympathetic Nervous System; Physostigmine; Psychotic Disorders; Research Design; Schizophrenia; Tranquilizing Agents	1975
Modification of involuntary movements by centrally acting drugs. Advances in neurology, 1975, Volume: 9 Topics: Aminooxyacetic Acid; Animals; Atropine; Bicuculline; Bromocriptine; Dopamine; Haloperidol; Haplorhini; Levodopa; Movement Disorders; Physostigmine; Picrotoxin; Piperazines; Piribedil; Receptors, Drug; Synaptic Transmission; Thalamic Nuclei; Theophylline	1975
Experimental models of oculomotor dysfunction in the rhesus monkey. Advances in neurology, 1975, Volume: 10 Topics: Adrenergic alpha-Antagonists; Animals; Corpus Callosum; Disease Models, Animal; Eye Diseases; Eye Movements; Eyelids; Ganglia, Autonomic; Guanethidine; Hyperthyroidism; Macaca mulatta; Movement Disorders; Nystagmus, Pathologic; Oculomotor Nerve; Ophthalmoplegia; Physostigmine; Pons; Pupil	1975
Acute dystonia as an idiosyncratic response to neuroleptics in baboons. Brain : a journal of neurology, 1977, Volume: 100, Issue:2 Topics: 5-Hydroxytryptophan; Acute Disease; Animals; Apomorphine; Corpus Striatum; Disease Models, Animal; Haloperidol; Haplorhini; Humans; Levodopa; Movement Disorders; Papio; Parasympatholytics; Physostigmine; Pimozide; Receptors, Dopamine; Reserpine; Syndrome; Tranquilizing Agents	1977
Methylphenidate-induced choreoathetosis. The American journal of psychiatry, 1978, Volume: 135, Issue:2 Topics: Female; Haloperidol; Humans; Methapyrilene; Methylphenidate; Middle Aged; Movement Disorders; Physostigmine; Receptors, Dopamine	1978
Spontaneous orofacial dyskinesias in a captive cynomolgus monkey: implications for tardive dyskinesia. Movement disorders : official journal of the Movement Disorder Society, 1990, Volume: 5, Issue:4 Topics: Animals; Benzazepines; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Facial Expression; Facial Muscles; Haloperidol; Macaca fascicularis; Mastication; Movement Disorders; Physostigmine; Scopolamine; Stereotyped Behavior	1990
Hyperactive vestibulo-ocular reflex in cerebellar degeneration: pathogenesis and treatment. Neurology, 1987, Volume: 37, Issue:1 Topics: Atrophy; Cerebellum; Eye Movements; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Movement Disorders; Physostigmine; Reflex, Vestibulo-Ocular	1987
Physostigmine in tardive dyskinesia. Lancet (London, England), 1972, Dec-30, Volume: 2, Issue:7792 Topics: Humans; Movement Disorders; Physostigmine	1972
The effect of physostigmine and tetrabenazine on spinal motor control and its inhibition by drugs which influence reserpine rigidity. Naunyn-Schmiedebergs Archiv fur experimentelle Pathologie und Pharmakologie, 1969, Volume: 263, Issue:3 Topics: 1-Propanol; Animals; Atropine; Biperiden; Dihydroxyphenylalanine; Electric Stimulation; Electromyography; Methamphetamine; Motor Neurons; Movement Disorders; Parasympatholytics; Phenytoin; Physostigmine; Piperidines; Rats; Reserpine; Spinal Cord; Spinal Nerves; Tetrabenazine; Trihexyphenidyl	1969
[Monoamines and choreic syndromes]. Revue neurologique, 1972, Volume: 127, Issue:1 Topics: Amines; Butyrophenones; Chorea; Diazepam; Dihydroxyphenylalanine; Dopamine; Ganglia; Globus Pallidus; Homovanillic Acid; Humans; Huntington Disease; Mental Disorders; Methyldopa; Methyltyrosines; Models, Neurological; Movement Disorders; Phenothiazines; Physostigmine; Reserpine; Thalamus; Tranquilizing Agents; Tyrosine	1972
Cholinergic suppression of tardive dyskinesia. Psychopharmacologia, 1974, Jun-21, Volume: 37, Issue:4 Topics: Acetylcholine; Aged; Binding Sites; Brain; Dopamine; Female; Humans; Hyperkinesis; Injections, Intravenous; Male; Middle Aged; Movement Disorders; Physostigmine; Schizophrenia; Synaptic Transmission; Time Factors; Tranquilizing Agents	1974
Effect of cholinergic and anticholinergic agents on tardive dyskinesia. Journal of neurology, neurosurgery, and psychiatry, 1974, Volume: 37, Issue:8 Topics: Adult; Aged; Anxiety Disorders; Edrophonium; Female; Humans; Male; Middle Aged; Movement Disorders; Neurocognitive Disorders; Physostigmine; Schizophrenia; Scopolamine; Tranquilizing Agents	1974
Cholinergic and anticholinergic influences on amphetamine-induced stereotyped behavior. Journal of the neurological sciences, 1972, Volume: 17, Issue:3 Topics: Amphetamine; Animals; Behavior, Animal; Dopamine; Drug Antagonism; Drug Synergism; Guinea Pigs; Male; Movement Disorders; Physostigmine; Scopolamine	1972
Reversal by levodopa of cholinergic hypersensitivity in Parkinson's disease. The New England journal of medicine, 1971, Feb-25, Volume: 284, Issue:8 Topics: Brain; Dihydroxyphenylalanine; Dopamine; Drug Hypersensitivity; Female; Handwriting; Humans; Injections, Intravenous; Male; Middle Aged; Movement Disorders; Neurologic Manifestations; Neurons; Parasympatholytics; Parasympathomimetics; Parkinson Disease; Physostigmine; Stimulation, Chemical; Trihexyphenidyl; Tropanes	1971